Author

Mattias Mandorfer

Cirrhosis after the removal of the primary aetiological factor
Cirrhosis after the removal of the primary aetiological factor

Mattias Mandorfer

LATE-STAGE PRESENTATION OF CIRRHOSIS WITH DECOMPENSATION IS ALARMINGLY COMMON AND FAVORABLE OUTCOME IS ONLY OBSERVED WITH ETIOLOGIC THERAPY
LATE-STAGE PRESENTATION OF CIRRHOSIS WITH DECOMPENSATION IS ALARMINGLY COMMON AND FAVORABLE OUTCOME IS ONLY OBSERVED WITH ETIOLOGIC THERAPY

Mattias Mandorfer  et al.

CLINICAL IMPLICATIONS OF HEPATIC RECOMPENSATION UPON TREATMENT WITH URSODEOXYCHOLIC ACID IN PBC PATIENTS WITH DECOMPENSATED CIRRHOSIS
CLINICAL IMPLICATIONS OF HEPATIC RECOMPENSATION UPON TREATMENT WITH URSODEOXYCHOLIC ACID IN PBC PATIENTS WITH DECOMPENSATED CIRRHOSIS

Mattias Mandorfer  et al.

A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS

Mattias Mandorfer  et al.

DISTURBANCES IN SODIUM AND CHLORIDE HOMEOSTASIS PREDICT OUTCOMES IN STABLE AND CRITICALLY ILL PATIENTS WITH CIRRHOSIS – NOT TWO SIDES OF THE SAME COIN
DISTURBANCES IN SODIUM AND CHLORIDE HOMEOSTASIS PREDICT OUTCOMES IN STABLE AND CRITICALLY ILL PATIENTS WITH CIRRHOSIS – NOT TWO SIDES OF THE SAME COIN

Mattias Mandorfer  et al.

THE USE OF STATINS, METFORMIN, AND RAS INHIBITORS DID NOT IMPACT ON VARICEAL BLEEDING RISK AND MORTALITY - A LARGE, REAL-LIFE MULTICENTER STUDY OF PATIENTS WITH CIRRHOSIS
THE USE OF STATINS, METFORMIN, AND RAS INHIBITORS DID NOT IMPACT ON VARICEAL BLEEDING RISK AND MORTALITY - A LARGE, REAL-LIFE MULTICENTER STUDY OF PATIENTS WITH CIRRHOSIS

Mattias Mandorfer  et al.

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

Mattias Mandorfer  et al.

ENDOSCOPIC VARICEAL BAND LIGATION IS SAFE DESPITE LOW PLATELET COUNT AND HIGH INR
ENDOSCOPIC VARICEAL BAND LIGATION IS SAFE DESPITE LOW PLATELET COUNT AND HIGH INR

Mattias Mandorfer  et al.

DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)
DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)

Mattias Mandorfer  et al.

DECREASED PLATELET FUNCTION ASSESSED BY FLOW CYTOMETRY IS LINKED TO HEPATIC DECOMPENSATION AND MORTALITY IN ADVANCED CHRONIC LIVER DISEASE
DECREASED PLATELET FUNCTION ASSESSED BY FLOW CYTOMETRY IS LINKED TO HEPATIC DECOMPENSATION AND MORTALITY IN ADVANCED CHRONIC LIVER DISEASE

Mattias Mandorfer  et al.

IMPACT OF HEPATIC AND SYSTEMIC INFLAMMATION ON THE DYNAMIC COMPONENT OF PORTAL HYPERTENSION DURING DISEASE REGRESSION IN ALCOHOL-RELATED CIRRHOSIS
IMPACT OF HEPATIC AND SYSTEMIC INFLAMMATION ON THE DYNAMIC COMPONENT OF PORTAL HYPERTENSION DURING DISEASE REGRESSION IN ALCOHOL-RELATED CIRRHOSIS

Mattias Mandorfer  et al.

HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS
HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS

Mattias Mandorfer  et al.

ACUTE HAEMODYNAMIC RESPONSE TO INTRAVENOUS PROPRANOLOL PREDICTS DECOMPENSATION AND MORTALITY IN PATIENTS WITH CIRRHOSIS
ACUTE HAEMODYNAMIC RESPONSE TO INTRAVENOUS PROPRANOLOL PREDICTS DECOMPENSATION AND MORTALITY IN PATIENTS WITH CIRRHOSIS

Mattias Mandorfer  et al.

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

Mattias Mandorfer  et al.

HIGH HISTAMINE LEVELS ASSOCIATE WITH ACUTE-ON-CHRONIC LIVER FAILURE AND LIVER-RELATED DEATH IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
HIGH HISTAMINE LEVELS ASSOCIATE WITH ACUTE-ON-CHRONIC LIVER FAILURE AND LIVER-RELATED DEATH IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Mattias Mandorfer  et al.

SUPPRESSION OF THE PITUITARY-ADRENAL AXIS AND PROGNOSTIC VALUE OF SERUM CORTISOL IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
SUPPRESSION OF THE PITUITARY-ADRENAL AXIS AND PROGNOSTIC VALUE OF SERUM CORTISOL IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Mattias Mandorfer  et al.

THE IMPACT OF PNPLA3 RS738409 RISK G ALLELES ON HEPATIC STEATOSIS, THE METABOLIC SYNDROME AND PORTAL HYPERTENSION IN ADVANCED FATTY LIVER DISEASE
THE IMPACT OF PNPLA3 RS738409 RISK G ALLELES ON HEPATIC STEATOSIS, THE METABOLIC SYNDROME AND PORTAL HYPERTENSION IN ADVANCED FATTY LIVER DISEASE

Mattias Mandorfer  et al.

ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS
ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS

Mattias Mandorfer  et al.

PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER
PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER

Mattias Mandorfer  et al.

SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION

Mattias Mandorfer  et al.

Item 1 - 20 / 32
1
2